Time filter

Source Type

Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-04-26

The present invention relates to a dry process for the preparation of pharmaceutical compositions of tofacitinib comprising tofacitinib and one or more pharmaceutically acceptable excipients. Dry processes, such as direct compression or dry granulation, involve fewer and simpler process steps, thus preventing the loss of the active ingredient during processing.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-01-04

The present invention relates to pharmaceutical compositions comprising a solid dispersion of dapagliflozin and one or more pharmaceutically acceptable excipients, and processes for their preparation. It further relates to a method of treating diabetes using said pharmaceutical compositions.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-03-08

The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling polymer, wherein the cores are dispersed in a suspension base. It also relates to processes for the preparation of said extended release liquid compositions.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-02-28

The present invention relates to a pharmaceutical solution comprising isotretinoin or salts thereof. The present invention further relates to the processes for preparing such compositions.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-02-28

The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-06-21

A method of stabilizing linaclotide in a solid dosage form, said method comprising a) preparing a composition of linaclotide, acesulfame and pharmaceutically acceptable excipients and b) converting the composition into a solid dosage form.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-06-07

The present invention relates to a process for the preparation of palbociclib utilizing a silyl-protected crotonic acid derivative to produce a silyl-protected 2-chloro-4-(cyclopentylamino)-5-(1-methyl-2-carboxy-ethen-1-yl)pyrmidine followed by intramolecular cyclization of the pyrmidine intermediate to produce 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one which is then converted to palbociclib.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-06-07

The present invention relates to a dual-chamber pack for a multi-dose oral liquid pharmaceutical composition wherein the compositions of the first and second chambers are mixed at the time of first administration.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-06-07

The present invention provides an oral pharmaceutical composition of isotretinoin with reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.


Patent
Sun Pharmaceutical Industries Ltd | Date: 2017-06-21

The present invention provides crystalline Form I, Form II, Form III, Form IV, Form V, Form V-A, Form VI, Form VII, and Form VIII of palbociclib, processes for their preparation, pharmaceutical compositions comprising these crystalline forms, and their use for the treatment of cyclin-dependent kinase associated diseases.5

Loading Sun Pharmaceutical Industries Ltd. collaborators
Loading Sun Pharmaceutical Industries Ltd. collaborators